ARCHIVES

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

GAO Report Finds Hydrazine Sulfate Trials Were Accurate

September 29, 1995

NCAB Members Urge More Action In Support Of NCI.

December 15, 2006

New Drug Combination Shrinks Kidney Cancers

June 30, 2006

Milken Calls For Renewed War On Cancer, $20 Billion A Year International Effort

November 24, 1995

CCOPs ask NCI officials about one-year extensions.

May 20, 2005

NCI Advisors To Gain Increased Responsibility For Concept, Technical Merit Review Of Contracts

December 19, 1980